Asciminib (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Asciminib" in German language version.

refsWebsite

Global rank German rank

2^nd place

3^rd place

2clinicaltrials.gov

5,225^th place

2,461^st place

195^th place

255^th place

low place

low place

low place

low place

68^th place

29^th place

274^th place

152^nd place

447^th place

751^st place

4^th place

7^th place

43^rd place

985^th place

biomol.com

Biomol.com: Asciminib | CAS 1492952-76-7 | Cayman Chemical | Biomol.com, abgerufen am 14. November 2021.

clinicaltrials.gov

Klinische Studie (Phase 3): Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs bei Clinicaltrials.gov der NIH
Klinische Studie (Phase 1): A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL bei Clinicaltrials.gov der NIH

doi.org

P. Schuld et al.: Structural and Biochemical Studies Confirming the Mechanism of Action of Asciminib, an Agent Specifically Targeting the ABL Myristoyl Pocket (STAMP). Blood, Bd. 136 (Supplement 1), 2020, S. 34–35. doi:10.1182/blood-2020-140968
D. Rea et al.: A Phase 3, Open-Label, Randomized Study of Asciminib, a STAMP Inhibitor, vs Bosutinib in CML After ≥ 2 Prior TKIs. Blood. 2021. DOI: 10.1182/blood.2020009984.

europa.eu

ec.europa.eu

Eintrag EU/1/22/1670 im EU-Register für Humanarzneimittel, Europäische Kommission. Abgerufen am 26. August 2022.

fda.gov

accessdata.fda.gov

Prescribing Information Scemblix, Novartis Pharmaceuticals, Oktober 2021.

nih.gov

pubchem.ncbi.nlm.nih.gov

Externe Identifikatoren von bzw. Datenbank-Links zu Asciminibhydrochlorid: CAS-Nr.: 2119669-71-3, PubChem: 133082086, Wikidata: Q109581935.

novartis.com

FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia, Pressemitteilung Novartis, 20. Oktober 2021.

springer.com

link.springer.com

S. Wedekind: CML: Positive Daten zu STAMP-Inhibitor. Onkologie aktuell, 22. Februar 2021.

who.int

INN Recommended List 77, World Health Organisation (WHO), 9. März 2017.

wikidata.org

Externe Identifikatoren von bzw. Datenbank-Links zu Asciminibhydrochlorid: CAS-Nr.: 2119669-71-3, PubChem: 133082086, Wikidata: Q109581935.